期刊文献+

晚期糖基化终产物诱导血管内皮细胞骨架形态改变的机制 被引量:5

The Mechanism of Advanced Glycation End Products-Induced Morphological Changes of Actin Cytoskeleton in Endothelial Cells
下载PDF
导出
摘要 目的研究晚期糖基化终产物修饰蛋白对内皮细胞细胞骨架肌动蛋白的形态学影响及特异的糖基化终产物受体和氧化应激在此病理过程中的作用。方法用不同浓度的糖基化终产物修饰人血清白蛋白与人脐静脉内皮细胞株ECV304在体外共同培养不同时间,并设立对照组进行比较,采用免疫荧光染色法显示细胞骨架的形态学改变。结果与对照组相比,糖基化终产物修饰人血清白蛋白以时间和剂量依赖的方式影响内皮细胞骨架肌动蛋白聚合丝状和可溶性单体(或球状)形态的改变。随着糖基化终产物修饰人血清白蛋白作用浓度和时间的增加,丝状肌动蛋白所形成的外周致密带边缘出现锯齿样断裂,趋于变细崩解消散,最终形成由非极性单行排列的肌动蛋白丝组成的应力纤维。可溶性单体表现为向细胞浆和胞膜移位,胞浆区出现点状和丝状染色,细胞间距离明显增大。可溶性糖基化终产物受体的抗体和烟酰胺腺嘌呤二核苷酸磷酸盐氧化酶抑制剂均可阻断糖基化终产物对细胞骨架的影响。结论糖基化终产物修饰蛋白对细胞骨架的影响是通过与内皮细胞上的糖基化终产物受体结合并引起细胞内的氧化应激所介导的,这一作用可能与糖基化终产物所致血管通透性升高有关。 Aim To investigate the effect of advanced glycation end products (AGE) modified protein on morphological changes of actin cytoskeleton in endothelial cell and the role of receptor for AGE (RAGE) and oxidant stress in this pathological procedure. Methods Human umbiheal vein endothelial cells (hUVEC)-derived cell line (ECV304) were incubated with AGE modified human serum albumin (AGE-HSA) of concentrations of 12.5, 25, 50, and 100 mg/L respectively, for 2, 4, 8, 12 and 24 h. As control, HSA of the same concentration was administrated to ECV304 cells. To visualize the morphological changes of actin cytoskeleton, the treated cells were incubated with rhndamine-phalloidin or Oregon Green-Dnase I to stain F-actin or G-actin. ECV304 were treated with anti-RAGE IgG before AGE-HSA applications or both together. Apocynin, a specific inhibitor of NADPH oxidase, was pre-administrated to the endothelial ceils in concentrations of 10, 100,250, and 500μmol/L respectively, for 30 min, then the cells were rinsed with DMEM for three times and exposed to 50 mg/L AGE-HSA for 8 h. 31ae morphological changes of actin cyteskeleton were observed after the above-mentioned procedure. Results Morphology of Facfin and G-acfin in endothelial cells were changed greatly under the stimulation of AGE-HSA in a concentration and time-dependent manner. Exposure of ECs to AGE-HSA caused a shift in F-actin distribution from web-like structure to polymerized stress fiber. Cells subjected to higher-concentration and longer-time AGE-HSA exposure showed more and more stress fiber aceumnlation.Also the edge of G-actin became coarse and illegible and merged with each other, even formed tufts of flock extending all around nuclear area. And the changes can be inhibited by not only pretreatment with anti-RAGE IgG or NADPH oxidase inhibitor Apocynin, but also co-administrated with anti-RAGE IgG and AGE-HSA. The unmodified HSA, anti-RAGE IgG and Apocynin did not affect morphology of actin cytoskeleton. Conclusion AGE induced morphological changes of actin cytoskeleton in endothelial cells and it required receptor occupancy on cells surface and intracellnlar activation of NADPH oxidase.
出处 《中国动脉硬化杂志》 CAS CSCD 2005年第3期282-286,共5页 Chinese Journal of Arteriosclerosis
基金 广东省自然科学基金(10717) 国家自然科学基金(30028008) 国家重点基础研究发展规划973项目(G2000057004)
关键词 病理学与病理生理学 晚期糖基化终产物 细胞骨架 受体 晚期糖基化终产物 烟酰胺腺嘌呤二核苷酸磷酸盐氧化酶 动脉粥样硬化 Advanced Glycation End Products Cytoskeleton Receptor of Advanced Glycation End Products NADPH Oxidase Atherosclerosis
  • 相关文献

参考文献12

  • 1吴兴利,王士雯,杨中苏,徐雅琴,杨丁友,刘秀云.氧化型低密度脂蛋白对血管平滑肌细胞磷酸酶PTEN活性的影响[J].中国动脉硬化杂志,2002,10(6):505-508. 被引量:4
  • 2Leto G, Pricci F, Amadio L, Iacobini C, Cordone S, Diaz-Horta O, et al. Increased retinal endothelial cell monolayer permeability induced by the diabetic milieu:role of advanced non-enzymatic glycation and polyol pathway activation.Diabetes Metab Res, 2001, 17(6): 448-458.
  • 3Dudek SM, Garcia JN. Cytoskeletal regulation of pulmonary vaacular permeability. J Appl Physiol, 2001, 91(4): 1487-500.
  • 4Hou FF, Boyce J, Chertow GM, Kay J, Owen WF Jr. Aminoguanidine inhibits advanced glycation end products formation on beta-microglobulin. J Am Soc Nephrol, 1998, 9(2): 277-283.
  • 5肖彧君,李春霖,刘冰熔,黄爱龙,邓华聪.重组腺病毒IκBαM抑制高糖诱导的血管内皮细胞炎症因子的异常分泌[J].中国动脉硬化杂志,2004,12(3):259-262. 被引量:4
  • 6Ermert L, Bruckner H, Walmrath D, Grimminger F, Aktories K, Suttorp N, et al. Role of endothelial cytoskeleton in high-permeablilty edema due to botulinum C2 toxin in perfused rabbit lungs. Am J Physiol, 1995,268(5pt1):L753-761.
  • 7Bogatcheva NV, Garcia JG, Verin AD. Molecular mechanisms of therombin-in-duced endothelial cell permeability. Biochemistry (Mosc), 2002, 67(1): 75-84.
  • 8Schmidt AM, Yan SD, Wautier JL, Stern DM. Activation of receptor for advanced glycation end products:a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res, 1999, 84(5): 489-497.
  • 9Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL. Activaation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab,2001,280(5):E685-697.
  • 10Zhang L, Zalewski A, Liu Y, Mazurek T, Cowan S, Martin JL, et al. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation, 2003, 108(4): 472-478.

二级参考文献33

  • 1Sambrook J, Fritsh EF, Maniatis T.Molecular colning A laboratory Manul.3 rd ed.Beijing:Science Publishing House, 1992; 880-886
  • 2Lahiri DK, Ge Y.Electrophoretic mobility shift assay for the detection of specific DNA-protein complex in nuclear extracts from the cultured cells and frozen autopsy human brain tissue.Brain Res Brain Res Protoc, 2000, 5:257-265
  • 3Hm CG, Park JK, Hong SP.A high glucose concentration stimulates the expression of monocyte chemotactic peptide-1 in human mesangial cells.J Nephron, 1998, 79:33-37
  • 4Alanen K, Deng DX, Charkrabarti.Augmented expression of endothelin-1, endothelin-3 and endothelin-B receptor in breast carcinoma.Histopathology, 2000, 36 (1):161-167
  • 5Kim SH, Kang YJ, Kim WJ, Woo DK, Lee Y, Kim DI, et al.TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages.Circ J, 2004, 68 (4):396-399
  • 6Kitamoto S, Egashira K.Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases.Expert Rev Cardiovasc Ther, 2003, 1 (3):393-400
  • 7Pekdemir H, Cicek D, Camsari A, Akkus MN, Cin VG, Doven O, et al.The relationship between plasma endothelin-1, nitric oxide levels, and heart rate variability in patients with coronary slow flow.Ann Noninvasive Electrocardiol, 2004, 9 (1):24-33
  • 8Kirilov G, Tomova A, Dakovska L, Kumanov P, Shinkov A, Alexandrov AS.Elevated plasma endothelin as an additional cardiovascular risk factor in patients with Cushing's syndrome.Eur J Endocrinol, 2003, 149 (6):549-553
  • 9Amann K, Tyralla K, Gross ML, Eifert T, Adamczak M, Ritz E.Special characteristics of atherosclerosis in chronic renal failure.Clin Nephrol, 2003, 60 (7) Suppl 1:S13-21
  • 10Bousette N, Giaid A.Endothelin-1 in atherosclerosis and other vasculopathies.Can J Physiol Pharmacol, 2003, 81 (6):578-587

共引文献16

同被引文献64

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部